Literature DB >> 188049

Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.

E M Eicher, J L Southard, C R Scriver, F H Glorieux.   

Abstract

A new dominant mutation in the laboratory mouse, hypophosphatemia (gene symbol Hyp), has been identified. The Hyp gene is located on the X-chromosome and maps at the distal end. Mutant mice are characterized by hypophosphatemia, bone changes resembling rickets, diminished bone ash, dwarfism, and high fractional excretion of phosphate anion (low net tubular reabsorption). Phosphate supplementation of the diet from wearning prevents the appearance of severe skeletal abnormalities. The hypophosphatemic male mouse resembles human males with X-linked hypophosphatemia and the Hyp gene is presemably homologous with the X-linked human gene. The mouse model should facilitate study of the defect in transport of plasma inorganic phosphate anion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 188049      PMCID: PMC431589          DOI: 10.1073/pnas.73.12.4667

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  DETERMINATION ON A MICRO SCALE OF CONCENTRATION AND SPECIFIC RADIOACTIVITY OF INORGANIC PHOSPHATE IONS IN WHOLE BLOOD AND PACKED RED CELLS.

Authors:  B VESTERGAARD-BOGIND
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.

Authors:  F H Glorieux; C R Scriver; T M Reade; H Goldman; A Roseborough
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

3.  The distribution of p-aminohippuric acid in rat kidney slices. I. Tubular localization.

Authors:  R P Wedeen; B Weiner
Journal:  Kidney Int       Date:  1973-04       Impact factor: 10.612

4.  Animal models--a neglected medical resource.

Authors:  C E Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

5.  Familial hypophosphatemic rickets: defective transport of inorganic phosphate by intestinal mucosa.

Authors:  E M Short; H J Binder; L E Rosenberg
Journal:  Science       Date:  1973-02-16       Impact factor: 47.728

6.  Serum parathyroid hormone in X-linked hypophosphatemia.

Authors:  C Arnaud; F Glorieux; C Scriver
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6.

Authors:  E M Eicher; W G Beamer
Journal:  J Hered       Date:  1976 Mar-Apr       Impact factor: 2.645

8.  Loss of a parathyroid hormone-sensitive component of phosphate transport in X-linked hypophosphatemia.

Authors:  F Glorieux; C R Scriver
Journal:  Science       Date:  1972-03-03       Impact factor: 47.728

  8 in total
  112 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Osteomalacia and altered magnesium metabolism in the X-linked hypophosphatemic mouse.

Authors:  R A Meyer; J Jowsey; M H Meyer
Journal:  Calcif Tissue Int       Date:  1979-03-13       Impact factor: 4.333

4.  Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to 1,3-bis-(2-chloroethyl)-N-nitrosourea.

Authors:  C A Mackintosh; A E Pegg
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 5.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

6.  Response of jejunal phosphate absorption to 1,25-dihydroxyvitamin D(3) stimulationin vivo in young X-linked hypophosphatemic (Hyp) mice.

Authors:  R A Meyer; M H Meyer; R W Gray; B A Brault
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

7.  Cellular ATP synthesis mediated by type III sodium-dependent phosphate transporter Pit-1 is critical to chondrogenesis.

Authors:  Atsushi Sugita; Shinji Kawai; Tetsuyuki Hayashibara; Atsuo Amano; Takashi Ooshima; Toshimi Michigami; Hideki Yoshikawa; Toshiyuki Yoneda
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

Review 8.  Gene mapping of mineral metabolic disorders.

Authors:  R V Thakker; K E Davies; J L O'Riordan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

9.  Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice.

Authors:  Andrew C Karaplis; Xiuying Bai; Jean-Pierre Falet; Carolyn M Macica
Journal:  Endocrinology       Date:  2012-10-04       Impact factor: 4.736

10.  Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.

Authors:  Catherine A Brownstein; Junhui Zhang; Althea Stillman; Bruce Ellis; Nancy Troiano; Douglas J Adams; Caren M Gundberg; Richard P Lifton; Thomas O Carpenter
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.